Video Library
The Promise of Stem Cells
-
Prospects for bringing cell-based therapies into clinical practice
Martin McGlynn
President & CEO
StemCells, Inc.(Run Time: 00:01:47)
CNS Program
-
Evolution of stem cell research and its impact on the CNS field
Irving Weissman, MD
Chair, Scientific Advisory Board & Director
StemCells, Inc.(Run Time: 00:01:23)
-
CNS Program achievements and clinical development plans for HuCNS-SC® cells
Martin McGlynn
President & CEO
StemCells, Inc.(Run Time: 00:03:03)
-
Demonstrated human safety data for HuCNS-SC® cells
Stephen Huhn, MD, FACS, FAAP
Vice President & Head of the CNS Program
StemCells, Inc.(Run Time: 00:00:34)
-
Promise of human neural stem cells for treating CNS disorders
Stephen Huhn, MD, FACS, FAAP
Vice President & Head of the CNS Program
StemCells, Inc.(Run Time: 00:01:33)
Lysosomal Storage Disorders / NCL (Batten disease)
-
Preclinical proof of concept in Batten disease
Irving Weissman, MD
Chair, Scientific Advisory Board & Director
StemCells, Inc.(Run Time: 00:02:17)
Spinal Cord Injury
-
StemCells, Inc. Spinal Cord Injury trial and its importance for the field
Michael Fehlings, MD, PhD, FRCSC, FACS
Professor of Neurosurgery
University of Toronto(Run Time: 00:00:50)
-
Objectives for first trial in Spinal Cord Injury
Martin McGlynn
President & CEO
StemCells, Inc.(Run Time: 00:01:16)
-
Unique aspects of Spinal Cord Injury trial
Stephen Huhn, MD, FACS, FAAP
Vice President & Head of the CNS Program
StemCells, Inc.(Run Time: 00:00:52)
-
Potential of human neural stem cells to treat Spinal Cord Injury
Stephen Huhn, MD, FACS, FAAP
Vice President & Head of the CNS Program
StemCells, Inc.(Run Time: 00:01:31)
-
Strong preclinical case for use of HuCNS-SC® cells in Spinal Cord Injury
Aileen Anderson, PhD
Associate Professor
UC Irvine(Run Time: 00:02:28)
-
Human neural stem cells restore lost motor function in Spinal Cord Injury
Irving Weissman, MD
Chair, Scientific Advisory Board & Director
StemCells, Inc.(Run Time: 00:02:06)